PIER MARIA FORNASARI
2023-09-20

The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.

Brazilian researchers and collaborators in Germany and the US compiled data from 195 clinical trials conducted in 30 countries between January 2020 and December 2021. The findings are promising, although the authors stress the need for enhanced controls in the making of the products used in cell therapy. Their findings are reported in an article

Read More

No Comments InCELL THERAPY Covid-19
PIER MARIA FORNASARI
2023-09-20

American College of Phisicians issues updated Rapid, Living Practice Points on treating COVID-19 patients in outpatient settings

In an updated rapid, living practice points, the American College of Physicians (ACP) summarizes the latest evidence on the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting, specifically addressing the dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points from the American

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-09-20

Repeated doses of covid-19 vaccine provide strong protection for seniors

More and more frequent vaccine doses than in other countries reduce mortality in covid-19 in nursing homes. This is shown by a Swedish study, led by Anders Johansson and Mattias Forsell, Umeå University, which was published in the highly ranked journal Lancet Infectious Diseases. In the fight against covid-19, researchers have carefully studied the effectiveness

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-09-09

 SARS-CoV-2 infection and the development of islet autoimmunity in early childhood

Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin. While the cause of the autoimmunity reaction is still unclear, viral infections in young children are proposed to be critical environmental factors leading to type 1 diabetes. An international team of researchers from the Global Platform

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-09-09

Exercise-Induced Hormone Irisin May Reduce Alzheimer’s Disease Plaque and Tangle Pathology in the Brain

Key Takeaways Researchers who previously developed the first 3D human cell culture models of Alzheimer’s disease (AD) that displays two major hallmarks of the condition—the generation of amyloid beta deposits followed by tau tangles—have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology. As reported in the journal Neuron,

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2023-05-26

JAMA published large study provides deeper insight into long COVID symptoms

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment. Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-05-19

Study reveals novel action mechanism of corticosteroids in combating inflammation caused by COVID-19

Since the start of the COVID-19 pandemic, a class of corticosteroids called glucocorticoids (GCs) have become established as one of the main treatment options, especially for severe cases, thanks to their anti-inflammatory and immunosuppressant action. Brazilian researchers recently discovered new ways in which these drugs influence the organism’s inflammatory response during an infection: they raise

Read More

No Comments InCovid-19